Epithelial toxicity of alkylglycoside surfactants

Journal of Pharmaceutical Sciences

Volumn 102, Issue 1, 2013, Pages 114-125

  Vllasaliu, Driton ^a   Shubber, Saif ^a   Fowler, Robyn ^a   Garnett, Martin ^a   Alexander, Cameron ^a   Stolnik, Snow ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Alkylglycosides; Biocompatibility; Calu 3 cells; Dodecylmaltoside; Epithelial permeability; Permeation enhancers; Surfactants; Tetradecylmaltoside; Toxicology; Tridecylmaltoside

Indexed keywords

AKYLGLYCOSIDE; GLYCOSIDE; LIPOSOME; SURFACTANT; UNCLASSIFIED DRUG;

ARTICLE; CELL DEATH; CELL DIFFERENTIATION; CELL ENCAPSULATION; CELL MEMBRANE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; ELECTRIC RESISTANCE; EPITHELIAL TOXICITY; EPITHELIUM CELL; HUMAN; HUMAN CELL; RESPIRATORY EPITHELIUM; TOXICITY;

EID: 84870688859     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.23340     Document Type: Article

References (37)

1. Takatsuka S, Morita T, Koguchi A, Horikiri Y, Yamahara H, Yoshino H. 2006. Synergistic absorption enhancement of salmon calcitonin and reversible mucosal injury by applying a mucolytic agent and a non-ionic surfactant. Int J Pharm 316:124-130.
2. Takatsuka S, Kitazawa T, Morita T, Horikiri Y, Yoshino H. 2006. Enhancement of intestinal absorption of poorly absorbed hydrophilic compounds by simultaneous use of mucolytic agent and non-ionic surfactant. Eur J Pharm Biopharm 62:52-58.
3. Morimoto K, Miyazaki M, Kakemi M. 1995. Effects of proteolytic enzyme inhibitors on nasal absorption of salmon calcitonin in rats. Int J Pharm 113:1-8.
4. Vllasaliu D, Casettari L, Fowler R, Exposito-Harris R, Garnett M, Illum L, Stolnik S. 2012. Absorption-promoting effects of chitosan in airway and intestinal cell lines: A comparative study. Int J Pharm 430:151-160.
5. Casettari L, Vllasaliu D, Mantovani G, Howdle SM, Stolnik S, Illum L. 2010. Effect of PEGylation on the toxicity and permeability enhancement of chitosan. Biomacromolecules 11:2854-2865.
6. Vllasaliu D, Exposito-Harris R, Heras A, Casettari L, Garnett M, Illum L, Stolnik S. 2010. Tight junction modulation by chitosan nanoparticles: Comparison with chitosan solution. J Pharm Sci 400:183-193.
7. Arnold JJ, Ahsan F, Meezan E, Pillion DJ. 2004. Correlation of tetradecylmaltoside induced increases in nasal peptide drug delivery with morphological changes in nasal epithelial cells. J Pharm Sci 93:2205-2213.
8. Pillion DJ, Hosmer S, Meezan E. 1998. Dodecylmaltoside-mediated nasal and ocular absorption of lyspro-insulin: Independence of surfactant action from multimer dissociation. Pharm Res 15:1637-1639.
9. Pillion DJ, Atchison JA, Gargiulo C, Wang RX, Wang P, Meezan E. 1994. Insulin delivery in nosedrops: New formulations containing alkylglycosides. Endocrinology 135:2386-2391.
10. Pillion DJ, Wang P, Yorks J, McCann P, Meezan E. 1995. Systemic absorption of insulin and glucagon applied topically to the eyes of rats and a diabetic dog. J Ocul Pharmacol Ther 11:283-295.
11. Ahsan F, Arnold J, Meezan E, Pillion DJ. 2001. Enhanced bioavailability of calcitonin formulated with alkylglycosides following nasal and ocular administration in rats. Pharm Res 18:1742-1746.
12. Arnold J, Ahsan F, Meezan E, Pillion DJ. 2002. Nasal administration of low molecular weight heparin. J Pharm Sci 91:1707-1714.
13. Eddy P, Krause D, Merutka G, MacDonald B. 2008. Intranasal (IN) pharmacokinetics (PK) and bioavailability of ZT-031, a novel parathyroid hormone (PTH) analog. ASBMR 30th Annual Meeting. Montréal, Québec, Canada: ASBMR.
14. Aegis Therapeutics. Accessed January 25, 2010, at: http://www.aegisthera.com/.
15. Ahsan F, Arnold JJ, Yang T, Meezan E, Schwiebert EM, Pillion DJ. 2003. Effects of the permeability enhancers, tetradecylmaltoside and dimethyl-beta-cyclodextrin, on insulin movement across human bronchial epithelial cells (16HBE14o-). Eur J Pharm Sci 20:27-34.
16. Bagger MA, Nielsen HW, Bechgaard E. 2001. Nasal bioavailability of peptide T in rabbits: Absorption enhancement by sodium glycocholate and glycofurol. Eur J Pharm Sci 14:69-74.
17. Mustafa F, Yang T, Khan MA, Ahsan F. 2004. Chain length-dependent effects of alkylmaltosides on nasal absorption of enoxaparin. J Pharm Sci 93(3):675-683.
18. Eley JG, Triumalashetty P. 2001. in vitro assessment of alkylglycosides as permeability enhancers. AAPS PharmSciTech 2:E19.
19. de la Maza A, Parra JL 1997. Solubilizing effects caused by the nonionic surfactant dodecylmaltoside in phosphatidylcholine liposomes. Biophys J 72:1668-1675.
20. Ericsson CA, Soderman O, Garamus VM, Bergstrom M, Ulvenlund S. 2005. Effects of temperature, salt, and deuterium oxide on the self-aggregation of alkylglycosides in dilute solution. 2. n-Tetradecyl-beta-d-maltoside. Langmuir 21:1507-1515.
21. Shinichiro H, Takatsuka Y, Hiroyuki M. 1981. Effect of surfactants on the nasal absorption of insulin in rats. Int J Pharm 9:165-172.
22. Duchateau GS, Zuidema J, Basseleur SWJ. 1987. Influence of some surface-active agents on nasal absorption in rabbits. Int J Pharm 39:87-92.
23. Novakovic ZM, Leinung MC, Lee DW, Grasso P. 2009. Intranasal administration of mouse [D-Leu-4]OB3, a synthetic peptide amide with leptin-like activity, enhances total uptake and bioavailability in Swiss Webster mice when compared to intraperitoneal, subcutaneous, and intramuscular delivery systems. Regul Pept 154:107-111.
24. Kragh-Hansen U, Hellec F, de Foresta B, le Maire M, Moller JV. 2001. Detergents as probes of hydrophobic binding cavities in serum albumin and other water-soluble proteins. Biophys J 80:2898-2911.
25. Silva CM, Veiga F, Ribeiro AJ, Zerrouk N, Arnaud P. 2006. Effect of chitosan-coated alginate microspheres on the permeability of Caco-2 cell monolayers. Drug Dev Ind Pharm 32:1079-1088.
26. Decker T, Lohmann-Matthes ML. 1988. A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity. J Immunol Methods 115:61-69.
27. Hecht G, Pothoulakis C, LaMont JT, Madara JL. 1988. Clostridium difficile toxin A perturbs cytoskeletal structure and tight junction permeability of cultured human intestinal epithelial monolayers. J Clin Invest 82:1516-1524.
28. Narai A, Arai S, Shimizu M. 1997. Rapid decrease in transepithelial electrical resistance of human intestinal Caco-2 cell monolayers by cytotoxic membrane perturbents. Toxicol In Vitro 11:347-354.
29. Rossi A, Poverini R, Di Lullo G, Modesti A, Modica A, Scarino ML. 1996. Heavy metal toxicity following apical and basolateral exposure in the human intestinal cell line Caco-2. Toxicol In Vitro 10:27-36.
30. Prozialeck WC, Wellington DR, Lamar PC. 1993. Comparison of the cytotoxic effects of cadmium chloride and cadmium-metallothionein in LLC-PK1 cells. Life Sci 53:PL337-PL342.
31. Vllasaliu D, Shubber S, Garnett M, Alexander C, Eaton M, Stolnik S. 2012. Evaluation of calcium depletion as a strategy for enhancement of mucosal absorption of macromolecules. Biochem. Biophys. Res. Commun 418(1):128-133.
32. Rhoads DN, Eskin SG, McIntire LV. 2000. Fluid flow releases fibroblast growth factor-2 from human aortic smooth muscle cells. Arterioscler Thromb Vasc Biol 20:416-421.
33. Merrifield CJ, Moss SE, Ballestrem C, Imhof BA, Giese G, Wunderlich I, Almers W. 1999. Endocytic vesicles move at the tips of actin tails in cultured mast cells. Nat Cell Biol 1:72-74.
34. Tirumalasetty PP, Eley JG. 2006. Permeability enhancing effects of the alkylglycoside, octylglucoside, on insulin permeation across epithelial membrane in vitro. J Pharm Pharm Sci 9:32-39.
35. Hussain A, Ahsan F. 2006. Indication of transcytotic movement of insulin across human bronchial epithelial cells. J Drug Target 14:181-190.
36. Warisnoicharoen W, Lansley AB, Lawrence MJ. 2003. Toxicological evaluation of mixtures of nonionic surfactants, alone and in combination with oil. J Pharm Sci 92:859-868.
37. Inacio AS, Mesquita KA, Baptista M, Ramalho-Santos J, Vaz WL, Vieira OV. 2011. in vitro surfactant structure-toxicity relationships: Implications for surfactant use in sexually transmitted infection prophylaxis and contraception. PLoS One 6:e19850.